The significant neuroprotective effects obtained in our patients after intranasal NGF administration, without local or systemic side effects, open a new potential therapeutic window not only offering a rescue treatment in children with post-traumatic UWS but also in patients suffering from other neurodegenerative diseases characterized by the loss of neuronal function77. This evidence concerns the gene NGF and neurodegenerative disease.